Skip to content
10-Q

Quarterly Report

Agile Therapeutics, Inc.

0001558370-24-011904

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 12, 2024 6.9M sh
Shares Diluted Q2 2024 · Jun 30, 2024 6.86M sh
Shares Diluted Q2 2024 · Jun 30, 2024 5.74M sh
Shares Diluted Q2 2024 · Jun 30, 2023 1.77M sh
Shares Diluted Q2 2024 · Jun 30, 2023 1.34M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$2.24M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$10.11M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $2.85M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $2.56M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$21.91M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$10.32M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$16.32M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$12.12M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$9.43M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$5.55M
Current Liabilities Q2 2024 · Jun 30, 2024 $26.23M
Current Liabilities Q2 2024 · Dec 31, 2023 $20.78M
Total Liabilities Q2 2024 · Jun 30, 2024 $36.88M
Total Liabilities Q2 2024 · Dec 31, 2023 $26.57M
Current Assets Q2 2024 · Jun 30, 2024 $14.44M
Current Assets Q2 2024 · Dec 31, 2023 $9.53M
Total Assets Q2 2024 · Jun 30, 2024 $14.96M
Total Assets Q2 2024 · Dec 31, 2023 $10.26M
Eps Diluted Q2 2024 · Jun 30, 2024 −$1.73
Eps Diluted Q2 2024 · Jun 30, 2024 −$1.84
Eps Diluted Q2 2024 · Jun 30, 2023 −$2.15
Eps Diluted Q2 2024 · Jun 30, 2023 −$6.85
Eps Basic Q2 2024 · Jun 30, 2024 −$1.73
Eps Basic Q2 2024 · Jun 30, 2024 −$1.84
Eps Basic Q2 2024 · Jun 30, 2023 −$2.15
Eps Basic Q2 2024 · Jun 30, 2023 −$6.85
Sga Expense Q2 2024 · Jun 30, 2024 $2.51M
Sga Expense Q2 2024 · Jun 30, 2024 $5.13M
Sga Expense Q2 2024 · Jun 30, 2023 $3.05M
Sga Expense Q2 2024 · Jun 30, 2023 $6.13M
Rd Expense Q2 2024 · Jun 30, 2024 $538K
Rd Expense Q2 2024 · Jun 30, 2024 $1.03M
Rd Expense Q2 2024 · Jun 30, 2023 $703K
Rd Expense Q2 2024 · Jun 30, 2023 $1.47M
Net Income Q2 2024 · Jun 30, 2024 −$11.87M
Net Income Q2 2024 · Jun 30, 2024 −$10.59M
Net Income Q2 2024 · Mar 31, 2024 $1.28M
Net Income Q2 2024 · Jun 30, 2023 −$3.81M
Net Income Q2 2024 · Jun 30, 2023 −$9.2M
Net Income Q2 2024 · Mar 31, 2023 −$5.39M
Operating Income Q2 2024 · Jun 30, 2024 −$2.75M
Operating Income Q2 2024 · Jun 30, 2024 −$5.51M
Operating Income Q2 2024 · Jun 30, 2023 −$5.13M
Operating Income Q2 2024 · Jun 30, 2023 −$11.83M
Gross Profit Q2 2024 · Jun 30, 2024 $4.08M
Gross Profit Q2 2024 · Jun 30, 2024 $8.12M
Gross Profit Q2 2024 · Jun 30, 2023 $3.2M
Gross Profit Q2 2024 · Jun 30, 2023 $5.01M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $1.5M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $3.18M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $2.31M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $4.31M
Revenue Q2 2024 · Jun 30, 2024 $5.58M
Revenue Q2 2024 · Jun 30, 2024 $11.29M
Revenue Q2 2024 · Jun 30, 2023 $5.5M
Revenue Q2 2024 · Jun 30, 2023 $9.32M
Short Term Debt Q2 2024 · Dec 31, 2023 $1.52M